Opus Genetics Inc (IRD)
1.065
-0.02
(-2.29%)
USD |
NASDAQ |
Nov 14, 16:00
1.11
+0.04
(+4.23%)
After-Hours: 18:31
Opus Genetics Profit Margin (Quarterly): -698.3% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -698.3% |
| March 31, 2024 | -415.3% |
| December 31, 2023 | -283.6% |
| September 30, 2023 | 46.59% |
| June 30, 2023 | -135.0% |
| March 31, 2023 | -331.1% |
| December 31, 2022 | 85.17% |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | -865.0% |
| June 30, 2021 | -7.14K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-7.14K%
Minimum
Jun 2021
85.17%
Maximum
Dec 2022
-1.08K%
Average
-331.1%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Baxter International Inc | 5.19% |
| Syros Pharmaceuticals Inc | -- |
| Elanco Animal Health Inc | 35.34% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -31.40% |
| Return on Assets | -28.41% |
| Return on Invested Capital | -31.40% |
| Operating Margin (Quarterly) | -748.9% |
| Return on Net Operating Assets | -266.6% |